Executives:
1. Bassil I. Dahiyat, Ph.D. - President
2. John J. Kuch - Sr. Vice President
3. Edgardo Baracchini, M.D. - Chief Medical Officer
4. John Desjarlais, Ph.D. - Chief Scientific Officer
5. Paul Foster - Chief Financial Officer
6. Kurt Gustafson - Chief Administrative Officer
7. Wenqing Yao, M.D., Ph.D. - Chief Development Officer
Board of Directors:
1. Barbara K. Lencke - Director
2. Bassil I. Dahiyat, Ph.D. - Director
3. Kevin C. Gorman, Ph.D. - Director
4. Richard Ranieri - Director
5. Kurt Gustafson - Director
6. A. Bruce Montgomery, M.D. - Director
7. Ellen G. Feigal, M.D. - Director
8. Dagmar Rosa-Bjorkeson - Director ,
Xencor Inc currently has 260 employees.
News about Xencor Inc Key Personnel |
Xencor, a leading clinical-stage biopharmaceutical company specializing in engineered antibodies and cytokines, announced in a recent press release that Dane Leone, a seasoned financial expert, has joined the firm as the senior vice president of corporate strategy. This strategic appointment will bolster Xencor s ongoing efforts in enhancing its platform technologies and maximizing value across its revolutionary cancer and autoimmune disease treatments.
Dane Leone s Role at Xencor:
In his newly created position, Mr. Leone will collaborate closely with Xencor s research and development (RandD) leadership team. His primary responsibility will be to drive value optimization initiatives by ov...
|
